Position history for Hudson Bay Capital Management LP's holdings in BIOMARIN PHARMACEUTICAL INC
Hudson Bay Capital Management LP holds 974,776 shares of BMRN (BIOMARIN PHARMACEUTICAL INC), worth $55.1M as of 2026-Q1. The position was increased (+45.5% shares). BMRN represents 0.2% of Hudson Bay Capital Management LP's portfolio.
Current Value
$55.1M
Current Shares
974,776
Total Value Change
+$34.9M
Total Shares Change
+730,076
Other major holders of BMRN: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 974,776 |
+45.5% |
| $55.1M |
| 0.2% |
| $58.53 |
48 |
| 2025-Q4 | Decreased | 670,002 | -3.4% | $39.8M | 0.1% | $58.99 | 0 |
| 2025-Q3 | Increased | 693,894 | +31.8% | $37.6M | 0.1% | $54.02 | 44 |
| 2025-Q2 | Decreased | 526,420 | -10.3% | $28.9M | 0.1% | $55.17 | 0 |
| 2025-Q1 | Increased | 586,845 | +27.6% | $41.5M | 0.1% | $71.44 | 43 |
| 2024-Q4 | Increased | 460,000 | +4.3% | $30.2M | 0.1% | $65.45 | 36 |
| 2024-Q3 | Increased | 441,200 | +80.3% | $31M | 0.1% | $70.58 | 53 |
| 2024-Q2 | Increased | 244,700 | +122.7% | $20.1M | 0.1% | $82.33 | 46 |